Our advice for clinicians on the coronavirus is here.
If you are a member of the public looking for information and advice about coronavirus (COVID-19), including information about the COVID-19 vaccine, go to the NHS website. You can also find guidance and support on the GOV.UK website.
NHS England has today (Thursday 3 August) announced the start of a pioneering implementation trial to provide HIV prevention drugs to people at high risk of HIV infection. From September, pre-exposure prophylaxis (PrEP) will now be provided by the NHS through the initial three year trial to an estimated 10,000 people, in what will be […]
Children and adults with a rare inherited bone disease will be able to access a potentially life-enhancing drug, thanks to an innovative deal between NHS England, NICE and manufacturer Alexion. Hypophosphatasia (HPP) is a rare inherited bone condition that can appear any time from before birth to adulthood. In babies it is often fatal, and […]
NHS England has today confirmed that three new specialised treatments will be made available for patients in England. It is estimated that up to 145 people a year will meet the clinical criteria to benefit from the following treatment options being made routinely available to their clinicians with funding from NHS England: Second allogeneic haematopoietic […]
NHS England has today announced it will make up to £8m available over five years to fund the treatment costs of a five year clinical trial of mitochondrial donation – a form of IVF in which the future baby’s mitochondrial DNA comes from a donor egg, to avoid passing on inherited mitochondrial diseases. The decision […]
NHS England will fund a major extension to the national HIV prevention programme led by Public Health England with the aim of supporting those most at risk and reducing the incidence of HIV infection. It has also decided to routinely commission ten new specialised treatments as part of the annual prioritisation process for specialised treatments. […]
We welcome this judgment by the Court of Appeal which sets out three important rulings. First, it establishes that NHS England has the ability but not the obligation to fund PReP. Second, it means that should we decide to do so, we would not be subject to legal challenge on these grounds from rival ‘candidates’ […]
On 13 October 2016, NHS England launched a consultation on four related policies that describe how NHS England will make decisions on funding for treatments that are not currently routinely commissioned. The four policies are: in-year service developments, individual funding requests, funding experimental and unproven treatments, and continuing funding after clinical trials. The public consultation […]
NHS England today announced more details of the accelerated national reviews into paediatric critical care and specialised surgery for children. The reviews, which are part of NHS England’s regular round of specialised commissioning service reviews, would normally take up to two years to complete, but have been fast tracked to run in parallel with other […]
NHS England has today launched a consultation on four related policies that describe how NHS England will make decisions on funding for treatments that are not currently routinely commissioned. The four policies are: in-year service developments, individual funding requests, funding experimental and unproven treatments, and continuing funding after clinical trials. The public consultation, which launches […]
NHS England has today (05 October 2016) launched a 30 day public consultation on a clinical commissioning policy proposition for commissioning medicines in children. There has already been extensive engagement on this national policy, it has been developed with the support and input of lead clinicians and patient and public representatives. This approach has helped […]